TSX •
Healthcare •
Biotechnology •
Quote as of 06/24/2026 15:59
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeTSX
Market Capitalization9.58 mln
Float3.17 mln
Earnings Date05/12/2026
Piotroski F-Score
3
/ 9
Below average
Beneish M-Score
1.55
Highly suspicious
Relative Strength
29
/ 100
Underperforming
Debt / Equity
0.13
Very low leverage
ROE
48.08
Very strong
Dividend Yield
0.00%
No dividend
Business Description
COSCIENS Biopharma Inc., formerly known as Aeterna Zentaris Inc., is a Toronto-based life science company founded in 1990 that develops and sells products for the cosmetic, nutritional, and pharmaceutical industries across North America, Europe, and beyond. Its portfolio includes oat-derived ingredients such as beta glucan, oat oil, and avenanthramides, which are used to support health and address inflammation, as well as Macrilen, an oral treatment that stimulates growth hormone production. The company works with a network of licensed partners including Pharmanovia, Davimed GmbH, and the University of Alberta to bring its products to market.
